FDX1 and neoplasm: Similar to TCGA-LGG and TCGA-GBM, FDX1 was highly expressed in WHO IV (GBM) compared with WHO II, III (LGG), suggesting that other factors were intervening for FDX1 to affect the survival of tumor patients (Figure 7A).